Skip to content
10-Q

Quarterly Report

ENTEROLOGICS, INC.

0001477932-12-004284

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 12, 2012 37.16M sh
Capex Q3 2012 · Sep 30, 2012 $300K
Capex Q3 2012 · Sep 30, 2011 $300K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$411.48K
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$128.66K
Stockholders Equity Q3 2012 · Sep 30, 2012 $185.03K
Current Liabilities Q3 2012 · Sep 30, 2012 $321.18K
Current Liabilities Q3 2012 · Dec 31, 2011 $166.2K
Total Liabilities Q3 2012 · Sep 30, 2012 $387.85K
Total Liabilities Q3 2012 · Dec 31, 2011 $232.86K
Total Assets Q3 2012 · Sep 30, 2012 $572.88K
Total Assets Q3 2012 · Dec 31, 2011 $595.33K
Sga Expense Q3 2012 · Sep 30, 2012 $86.51K
Sga Expense Q3 2012 · Sep 30, 2011 $19.63K
Sga Expense Q3 2012 · Sep 30, 2011 $36.68K
Rd Expense Q3 2012 · Sep 30, 2012 $176K
Rd Expense Q3 2012 · Sep 30, 2011 $31K
Rd Expense Q3 2012 · Sep 30, 2011 $43.92K
Net Income Q3 2012 · Sep 30, 2012 −$698.66K
Net Income Q3 2012 · Sep 30, 2011 −$69.37K
Net Income Q3 2012 · Sep 30, 2011 −$155.01K
Current Assets Q3 2012 · Dec 31, 2011 $17.98K
Cost Of Revenue Q3 2012 · Dec 31, 2011 −$243.54K